ARTICLE | Clinical News
Mezavant mesalamine regulatory update
May 9, 2011 7:00 AM UTC
In February, Health Canada approved an expanded label for Mezavant mesalazine from Shire to include the maintenance of remission of ulcerative colitis (UC). The 5-aminosalicylate (5-ASA) mesalamine us...